Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 7927568, 9 pages
https://doi.org/10.1155/2018/7927568
Research Article

Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity

Joint International Research Laboratory of Ethnomedicine of Ministry of Education and Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China

Correspondence should be addressed to Feng Zhang; moc.361@cmzgnefgnahz

Received 16 March 2017; Revised 7 July 2017; Accepted 11 December 2017; Published 14 January 2018

Academic Editor: Fakhrul Islam

Copyright © 2018 Chun Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Lema Tomé, T. Tyson, N. L. Rey, S. Grathwohl, M. Britschgi, and P. Brundin, “Inflammation and α-synuclein’s prion-like behavior in Parkinson's disease—is there a link?” Molecular Neurobiology, vol. 47, no. 2, pp. 561–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Nilashi, O. Ibrahim, and A. Ahani, “Accuracy improvement for predicting Parkinson’s disease progression,” Scientific Reports, vol. 6, no. 1, article 34181, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. E. C. Hirsch, S. Vyas, and S. Hunot, “Neuroinflammation in Parkinson’s disease,” Parkinsonism & Related Disorders, vol. 18, Supplement 1, pp. S210–S212, 2012. View at Publisher · View at Google Scholar
  4. H. M. Gao and J. S. Hong, “Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression,” Trends in Immunology, vol. 29, no. 8, pp. 357–365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. X. F. Wu, M. L. Block, W. Zhang et al., “The role of microglia in paraquat-induced dopaminergic neurotoxicity,” Antioxidants & Redox Signaling, vol. 7, no. 5-6, pp. 654–661, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Zhang, C. H. Wang, F. Li, and W. Z. Zhu, “2,3,4,5-Tetrahydroxystilbene- 2-O-β-D-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 3, pp. 310–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Wang, J. Gu, P. F. Wu et al., “Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation,” Free Radical Biology & Medicine, vol. 47, no. 3, pp. 229–240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Shen, F.-l. Sun, R.-y. Zhang et al., “Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice,” Restorative Neurology and Neuroscience, vol. 33, no. 4, pp. 531–541, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zhang, L. H. Huang, L. Chen, D. Hao, and J. Chen, “Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson’s disease,” Toxicology Letters, vol. 222, no. 2, pp. 155–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Hou, Q. Liu, Y. Li, H. Sun, and J. Zhang, “An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson’s disease model rats,” BioMed Research International, vol. 2014, Article ID 850493, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Khuwaja, M. M. Khan, T. Ishrat et al., “Neuroprotective effects of curcumin on 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies,” Brain Research, vol. 1368, pp. 254–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Zhang, E. J. Shin, T. Wang et al., “3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro,” The FASEB Journal, vol. 20, no. 14, pp. 2496–2511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Zhang, L. Qian, P. M. Flood, J. S. Shi, J. S. Hong, and H. M. Gao, “Inhibition of IκB kinase-β protects dopamine neurons against lipopolysaccharide-induced neurotoxicity,” The Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 3, pp. 822–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. De Virgilio, A. Greco, G. Fabbrini et al., “Parkinson’s disease: autoimmunity and neuroinflammation,” Autoimmunity Reviews, vol. 15, no. 10, pp. 1005–1011, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Sanchez-Guajardo, C. J. Barnum, M. G. Tansey, and M. Romero-Ramos, “Neuroimmunological processes in Parkinson’s disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity,” ASN Neuro, vol. 5, no. 2, pp. AN20120066–AN20120139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Block, L. Zecca, and J. S. Hong, “Microglia-mediated neurotoxicity: uncovering the molecular mechanisms,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 57–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Chen, E. A. Oyarzabal, and J. S. Hong, “Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration,” Current Opinion in Pharmacology, vol. 26, pp. 54–60, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-J. Im, J. Hahm, H. Kang et al., “Disrupted brain metabolic connectivity in a 6-OHDA-induced mouse model of Parkinson’s disease examined using persistent homology-based analysis,” Scientific Reports, vol. 6, no. 1, article 33875, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Wasik, D. Polak, I. Romanska, J. Michaluk, and L. Antkiewicz-Michaluk, “The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson’s disease,” Pharmacological Reports, vol. 68, no. 6, pp. 1205–1213, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Pott Godoy, R. Tarelli, C. C. Ferrari, M. I. Sarchi, and F. J. Pitossi, “Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease,” Brain, vol. 131, no. 7, pp. 1880–1894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Choi, M. K. Lee, S. Y. Lim, S. H. Sung, and Y. C. Kim, “Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1β by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells,” British Journal of Pharmacology, vol. 156, no. 6, pp. 933–940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. Gao, F. Zhang, H. Zhou, W. Kam, B. Wilson, and J. S. Hong, “Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease,” Environmental Health Perspectives, vol. 119, no. 6, pp. 807–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Zhang, Y.-Y. Wang, J. Yang, Y.-F. Lu, J. Liu, and J.-S. Shi, “Tetrahydroxystilbene glucoside attenuates neuroinflammation through the inhibition of microglia activation,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 680545, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Herrera-Molina, B. Flores, J. A. Orellana, and R. von Bernhardi, “Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways,” Journal of Neurochemistry, vol. 123, no. 1, pp. 113–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. Hwang, H. P. Lee, D. Y. Choi et al., “Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation,” Oncotarget, vol. 7, no. 30, pp. 46943–46958, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Liu, Y. Deng, J. Gao et al., “Sodium hydrosulfide attenuates beta-amyloid-induced cognitive deficits and neuroinflammation via modulation of MAPK/NF-κB pathway in rats,” Current Alzheimer Research, vol. 12, no. 7, pp. 673–683, 2015. View at Publisher · View at Google Scholar
  27. H. S. Um, E. B. Kang, J. H. Koo et al., “Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease,” Neuroscience Research, vol. 69, no. 2, pp. 161–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. I. G. Onyango, J. B. Tuttle, and J. P. Bennett Jr., “Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson’s disease cybrids,” Molecular and Cellular Neurosciences, vol. 28, no. 3, pp. 452–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Qian, S.-J. Wei, D. Zhang et al., “Potent anti-inflammatory and neuroprotective effects of TGF-β1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia,” The Journal of Immunology, vol. 181, no. 1, pp. 660–668, 2008. View at Publisher · View at Google Scholar
  30. R. L. Miller, M. James-Kracke, G. Y. Sun, and A. Y. Sun, “Oxidative and inflammatory pathways in Parkinson’s disease,” Neurochemical Research, vol. 34, no. 1, pp. 55–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Wang, H. Zhang, M. Liu et al., “P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson’s disease,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 34, no. 8, pp. 1176–1180, 2014. View at Google Scholar
  32. Y. H. Jeong, Y.-C. Oh, W.-K. Cho, N.-H. Yim, and J. Y. Ma, “Anti-inflammatory effect of rhapontici radix ethanol extract via inhibition of NF-κB and MAPK and induction of HO-1 in macrophages,” Mediators of Inflammation, vol. 2016, Article ID 7216912, 13 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Strecker and J. Schwarz, “Parkinson’s disease: emerging pharmacotherapy,” Expert Opinion on Emerging Drugs, vol. 13, no. 4, pp. 573–591, 2008. View at Publisher · View at Google Scholar · View at Scopus